Quadruple negative breast cancer

ACSL4: Biomarker, Mediator and Target in Quadruple Negative Breast Cancer

Triple‑negative breast cancer: A run‑through of features

Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells via Apoptosis

Microfluidic Systems and Breast Cancer Metastasis

PDF] Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants

Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies

Chris Mason on X: @MeliD32 kicking off #AGBT24 today with an in-depth analysis of cancer disparities, some which started in the 1990s, and how TNBC affects African Americans with higher incidence, earlier

The clinical promise of immunotherapy in triple-negative breast cancer

Frontiers VNLG-152R and its deuterated analogs potently inhibit